Clinical Trials on Non-Hodgkin's Lymphoma Follicular
Total 5328 results
-
National Cancer Institute (NCI)TerminatedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Small Lymphocytic LymphomaUnited States
-
Masonic Cancer Center, University of MinnesotaRecruitingHodgkin Lymphoma | Non-Hodgkin LymphomaUnited States
-
Zhejiang UniversityYake Biotechnology Ltd.Not yet recruitingRelapsed and/or Refractory Acute Lymphoblastic Leukemia | Relapsed and/or Refractory B-cell Non-Hodgkin's LymphomaChina
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
University of MiamiTerminatedLymphoma | Follicular Lymphoma | Marginal Zone LymphomaUnited States
-
Seagen Inc.TerminatedLymphoma, Large B-Cell, Diffuse | Follicular Lymphoma, Grade 3b | Lymphoma, B-cell | Lymphoma, Follicular, Grade 3bUnited States
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
Duke UniversityCelgeneTerminatedFollicular Lymphoma | Marginal Zone LymphomaUnited States
-
Acepodia Biotech, Inc.RecruitingFollicular Lymphoma | B-cell Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | DLBCL | Primary Mediastinal Large B Cell LymphomaUnited States, Taiwan
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingStudy of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's LymphomaCD20-positive B-cell Non-Hodgkin's LymphomaChina
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedCD20 Positive B Cell Non-Hodgkin's LymphomaChina
-
Centre Henri BecquerelCompletedFollicular Lymphoma | Mantle Cell LymphomaFrance
-
National Cancer Institute (NCI)CompletedLymphoma, B-Cell | Leukemia, B-cell | Lymphoma, Hodgkins | Lymphoma, Non-hodgkinsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States
-
Genor Biopharma Co., Ltd.RecruitingB-cell Non-Hodgkin's LymphomaChina
-
Acibadem UniversityThe Scientific and Technological Research Council of Turkey; Acıbadem Labcell; Acıbadem Atunizade HospitalUnknownStudy of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL (ISIKOK-19)Acute Lymphoblastic Leukemia | Non Hodgkin LymphomaTurkey
-
PeproMene Bio, Inc.City of Hope Medical CenterRecruitingRelapsed or Refractory B-cell Non-Hodgkin's LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityWest China Hospital; Affiliated Hospital of Jiangnan University; The Affiliated... and other collaboratorsRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
Hutchison Medipharma LimitedRecruitingFollicular Lymphoma | Marginal Zone LymphomaChina
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
National Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States
-
SIRPant Immunotherapeutics, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
La Raza Medical CenterCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaMexico
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | B-Cell Non-Hodgkin Lymphomas(NHL)China
-
Ruijin HospitalUnknownDiffuse Large B-cell Lymphoma | Follicular Lymphoma Grade 3BChina
-
AmgenCompletedLymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Oncology | Hematology
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Follicular Lymphoma | Relapsed/Refractory Large B Cell LymphomaUnited States
-
Carna Biosciences, Inc.RecruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | B-cell MalignancyUnited States
-
Peking Union Medical College HospitalPeking University First Hospital; Chinese PLA General Hospital; Peking University... and other collaboratorsRecruitingT Cell Non-Hodgkin's LymphomaChina
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
Calithera Biosciences, IncTerminatedLymphoma, Non-Hodgkin | Lymphoma, Follicular, Marginal ZoneKorea, Republic of, Japan
-
National Cancer Institute (NCI)TerminatedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular LymphomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene CorporationCompletedRecurrent Follicular LymphomaUnited States
-
Medical College of WisconsinRecruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Central Nervous System Lymphoma | Mantle Cell Lymphoma (MCL) | Non Hodgkin Lymphoma (NHL)United States
-
Chinese PLA General HospitalRecruiting
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingNon-hodgkin's LymphomaChina
-
University of California, DavisCelgeneActive, not recruitingNon Hodgkin's LymphomaUnited States
-
Chipscreen Biosciences, Ltd.CompletedChiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's LymphomaNon-hodgkin's LymphomaChina
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei Hospital; Beijing Lu Daopei HospitalUnknownNon-hodgkin's LymphomaChina
-
Indiana University School of MedicineGenzyme, a Sanofi CompanyCompletedNon Hodgkin's LymphomaUnited States
-
Shanghai Zhongshan HospitalRecruitingLymphoma | Hodgkin Lymphoma | Non-hodgkin LymphomaChina
-
ADC Therapeutics S.A.CompletedHodgkin Lymphoma | Non-Hodgkin LymphomaUnited States, United Kingdom
-
Juventas Cell Therapy Ltd.Not yet recruiting
-
Sun Yat-sen UniversityRecruitingNon-hodgkin LymphomaChina
-
Swiss Group for Clinical Cancer ResearchTerminatedNon-Hodgkin LymphomaSwitzerland
-
Gilead SciencesTerminatedNon-Hodgkin LymphomaUnited States, France
-
University of Wisconsin, MadisonGenentech, Inc.TerminatedMantle Cell Lymphoma | Non Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States